StockWatch
·
Medical Specialities
AcquisitionsJun 8, 2026, 07:06 AM

Aclarion Rejects Echo Lake Capital's $4.00/Share Acquisition Bid

AI Summary

Aclarion, Inc. announced that its Board of Directors unanimously rejected an unsolicited public proposal from Echo Lake Capital to acquire the Company at $4.00 per share. The Board determined that the proposal significantly undervalues Aclarion and its strategic potential, and that its structure would disproportionately benefit Echo Lake. Aclarion stated that its cash on the balance sheet would effectively finance Echo Lake's acquisition, allowing them to acquire the Nociscan business and other assets at a substantial discount. The Board remains committed to pursuing credible paths to value creation for all shareholders.

Key Highlights

  • Aclarion's Board unanimously rejected Echo Lake Capital's unsolicited acquisition proposal.
  • The proposal offered to acquire Aclarion at $4.00 per share.
  • The Board believes the proposal significantly undervalues the Company and its strategic potential.
  • The proposal's structure would disproportionately benefit Echo Lake at other shareholders' expense.
  • Aclarion's cash on the balance sheet would effectively finance Echo Lake's acquisition.
  • The Board remains committed to pursuing credible paths to value creation for all shareholders.